Automated Blood Collection Market Report 2025

This automated blood collection market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The automated blood collection market size has grown rapidly in recent years. It will grow from $1.29 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to government programs to encourage blood donation, increase in number of product approvals, rise in number of specimens.

The automated blood collection market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to rising infectious diseases, high demand for blood donations, rising demand for sophisticated blood collection, and growing preference for liquid biopsy testing. Major trends in the forecast period include technological innovations, automation of blood collection lowers risk, new product design, innovations in portable blood collection, and product innovation.

A significant rise in blood donation is expected to drive the growth of the automated blood collection market. The increase in blood donation is attributed to several factors, including heightened awareness of the critical need for blood in emergency situations, widespread donation drives organized by health organizations and community groups, and advancements in medical technology that enhance the safety and efficiency of the donation process. Automated blood collection supports this trend by streamlining and improving the efficiency of the process, reducing the need for manual intervention and minimizing human error and donor discomfort. For example, in 2024, NHS Blood and Transplant (NHSBT), a UK-based health authority serving England and Wales, reported 119,371 new blood donations for the 2023-2024 period, a modest increase from 119,016 donations in 2022-2023. Thus, the significant rise in blood donation is driving the growth of the automated blood collection market.

Major companies in the automated blood collection market are developing innovative products with advanced technologies, such as PentaPoint technology, to improve the precision and efficiency of blood collection. PentaPoint technology enhances the accuracy and control of the collection process by using multiple entry points, which helps reduce discomfort and improve sample quality. For example, in April 2024, Becton, Dickinson, and Company, a US-based medical company, introduced the BD Vacutainer UltraTouch Push Button Blood Collection Set in India and the US. This new device is designed to minimize patient pain and discomfort during blood collection. It incorporates BD RightGauge technology, which features a thinner needle, and BD PentaPoint technology, which significantly reduces insertion pain. The device also includes BD Push Button Technology, which decreases the risk of needle injuries by 88%. This advanced blood collection set aims to enhance patient comfort, improve vein access for clinicians, and shorten overall procedure times.

In May 2022, Babson Diagnostics, a US-based healthcare technology company, partnered with Becton, Dickinson, and Company to advance healthcare solutions and enhance patient outcomes through collaboration and innovation. This partnership aims to focus on creating innovative solutions that improve patient care and streamline the blood collection process with automated sampling, especially in settings where traditional methods may not be practical. Becton, Dickinson, and Company is a US-based medical device company that includes automated blood collection systems in its offerings.

Major companies operating in the automated blood collection market are Abbott Laboratories, RHI Group, Siemens Healthineers, Becton, Dickinson and Company, CSL Plasma, Quest Diagnostics Incorporated, B. Braun Melsungen AG, Fresenius KABI AG, Grifols S.A., Terumo Corporation, Nipro Medical Corporation, Greiner AG, Bio-Rad Laboratories Inc., ICU Medical Inc., QIAGEN N.V., Haemonetics Corporation, SARSTEDT AG & Co. KG, Owen Mumford Ltd., Retractable Technologies Inc., Neomedic Limited, CML Biotech, Macopharma, Chengdu Rich Science Industry Co. Ltd., Babson Diagnostics, Venibot.

North America was the largest region in the automated blood collection market in 2024. The regions covered in the automated blood collection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated blood collection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Automated blood collection involves using advanced technology and automated systems to efficiently and accurately collect blood samples from patients. These systems reduce the need for manual intervention, enhancing accuracy, minimizing errors, and improving patient comfort and safety. Automated blood collection is utilized in medical laboratories and healthcare settings to ensure reliable and consistent sample handling.

The main types of automated blood collection include arterial sampling, venipuncture sampling, and fingerstick sampling. Arterial sampling involves drawing blood from an artery, such as the radial or femoral artery, for diagnostic testing. Applications of automated blood collection span diagnostics, treatment, and therapeutics. End-users of these systems include hospitals, diagnostic centers, pathology laboratories, and other healthcare facilities.

The automated blood collection market research report is one of a series of new reports that provides automated blood collection market statistics, including automated blood collection industry global market size, regional shares, competitors with an automated blood collection market share, detailed automated blood collection market segments, market trends and opportunities, and any further data you may need to thrive in the automated blood collection industry. This automated blood collection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated blood collection market consists of revenues earned by entities by providing services such as maintenance services, calibration, and technical support for their machines. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated blood collection market also includes sales of collection bags, needles, tubing sets, and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.